Patient Square Capital Lp Portfolio Stock Holdings
Patient Square Capital Lp disclosed 29 stock positions valued at approximately $563.6 million in its latest SEC 13F filing. The largest holdings include ROIVANT SCIENCES LTD, ARGENX SE, and INSMED INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 29
- Portfolio Value
- $563.6M
Holdings by Sector
Patient Square Capital Lp Portfolio Holdings in Q1 2026
26 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | G76279101 | Other | 40.13% | 8,166,047 | - | - | $226,199,502 |
| ARGENX SE | ARGX | Healthcare | 4.76% | 36,718 | +10,718 | +41.22% | $26,813,320 |
| INSMED INC | INSM | Healthcare | 4.57% | 157,500 | -109,500 | -41.01% | $25,754,400 |
| BEONE MEDICINES LTD | BGNE | Healthcare | 4.24% | 80,542 | +11,230 | +16.20% | $23,918,558 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 4.07% | 596,000 | +278,628 | +87.79% | $22,940,040 |
| MIRUM PHARMACEUTICALS INC | MIRM | Healthcare | 3.77% | 230,000 | -68,682 | -23.00% | $21,247,400 |
| BELITE BIO INC | BLTE | Healthcare | 3.30% | 116,684 | +116,684 | +100.00% | $18,604,097 |
| LEGEND BIOTECH CORP | LEGN | Healthcare | 3.18% | 990,000 | +990,000 | +100.00% | $17,909,100 |
| PHARVARIS N V | PHVS | Other | 2.47% | 493,000 | -49,696 | -9.16% | $13,927,250 |
| ABIVAX SA | ABVX | Healthcare | 2.40% | 121,245 | -8,755 | -6.73% | $13,500,631 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 2.34% | 227,000 | +90,500 | +66.30% | $13,200,050 |
| CELCUITY INC | CELC | Healthcare | 1.92% | 95,000 | -25,000 | -20.83% | $10,843,300 |
| EYEPOINT INC | EYPT | Healthcare | 1.82% | 795,000 | +15,000 | +1.92% | $10,247,550 |
| MERCK & CO INC | MRK | Healthcare | 1.71% | 80,000 | +80,000 | +100.00% | $9,623,200 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 1.67% | 400,645 | +190,645 | +90.78% | $9,439,196 |
| ALLOGENE THERAPEUTICS INC | ALLO | Healthcare | 1.49% | 3,450,000 | -1,513,756 | -30.50% | $8,418,000 |
| KYMERA THERAPEUTICS INC | KYMR | Healthcare | 1.48% | 100,000 | -39,000 | -28.06% | $8,329,000 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 1.40% | 93,882 | -56,118 | -37.41% | $7,878,577 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 1.39% | 200,000 | -108,141 | -35.09% | $7,840,000 |
| PERSPECTIVE THERAPEUTICS INC | CATX | Healthcare | 1.20% | 1,625,000 | +492,185 | +43.45% | $6,776,250 |
| HARROW INC | HROW | Healthcare | 1.03% | 165,209 | +158,178 | +2249.72% | $5,825,269 |
| PROTARA THERAPEUTICS INC | TARA | Healthcare | 0.95% | 1,030,846 | +1,030,846 | +100.00% | $5,370,708 |
| CYTOMX THERAPEUTICS INC. | CTMX | Healthcare | 0.91% | 1,085,790 | +1,085,790 | +100.00% | $5,103,213 |
| ARCUS BIOSCIENCES INC | RCUS | Healthcare | 0.75% | 195,000 | +25,000 | +14.71% | $4,212,000 |
| ASSEMBLY BIOSCIENCES INC | ASMB | Healthcare | 0.67% | 136,315 | +9,315 | +7.33% | $3,782,741 |
| SPYRE THERAPEUTICS INC | SYRE | Healthcare | 0.01% | 1,000 | -149,000 | -99.33% | $50,440 |